story of the week
Discontinuation of Disease-Modifying Therapy in Multiple Sclerosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Discontinuation of Disease-Modifying Therapy in Multiple Sclerosis: Should We Stay or Should We Go?
JAMA Neurol 2021 Jul 01;78(7)787-788, EMM Strijbis, A Kerbrat, JR CorboyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.